To identify compounds able to smoothen/mask the bitter taste of food ingredients such as cocoa, high intensity sweeteners, whole grains, etc.
The Bitter Platform comprises all 25 human bitter taste receptors (hTAS2Rs) expressed in specific recipient cell lines for functional analysis.
The platform is suitable to identify the specific TAS2Rs activated by a compound and/or to identify compounds positively or negatively interacting with specific TAS2R receptors.
To identify novel compounds with direct or modulating cooling, tingling and hot/spicy properties
The Trigeminal Platform comprises a panel of cell-based assays for detectors responsible for the somatosensory perception of cool, hot, and tingling (TRPM8, TRPA1, TRPV1).
This platform allows for the identification of novel compounds with direct or modulating cooling, tingling and hot properties with the help of specific assays involving members of transient receptor potential (TRP) channels.
Fatty Acid Receptor Platform
To identify compounds able to improve satiety and tackle obesity
The Fatty Acid Receptor Platform allows for the identification of food ingredients which:
- Act on fatty acid taste receptors
- Modulate or increase the response of receptors responsive to fatty acids
- Trigger the release of hormones related to hunger-satiety cycle (via downstream signaling mechanisms)
The platform comprises functional cell-based assays for GPCRs involved in fatty acid detection and metabolism including GPR120, GPR40 , GPR43, TGR5, and GPR119.
To identify compounds able to activate/enhance the functionality of salt receptors
IMAX Discovery has developed a Salt Platform that comprises functional cell-based assays for the known human salt receptors in order to identify novel ingredients helping to reduce the use of salt in food and beverages.
IMAX Discovery offers the capabilities to validate new potential salt receptors and develop related functional cell-based assays.